# AmVac

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amvac

- Industry: Pharmaceuticals
- Headquarters: Zug, Switzerland
- Website: www.amvac.eu
- Total disclosed funding: $2.8M
- Latest round: Series A (Feb 11, 2010)
- Investors on record: 1

## About

AmVac AG is a Swiss company that specializes in developing innovative crop protection products and biopesticides aimed at enhancing sustainable agricultural practices across Europe.Founded in 2005 and headquartered in Zug, Switzerland, AmVac AG focuses on agricultural innovation, specifically in crop protection. The company has undergone strategic pivots to enhance its product offerings. AmVac AG has successfully completed five funding deals, with the latest round being a GRANT of EUR 5.50 mn completed on November 15, 2013. The total amount raised by the company is EUR 2.80 mn, demonstrating its capability to attract investment in its vision for sustainable agriculture.AmVac AG specializes in providing innovative solutions within the agricultural sector, focusing primarily on crop protection products and biopesticides. Their core offerings include environmentally friendly pesticides designed to mitigate pests while promoting sustainable agricultural practices. These products cater to diverse clientele, including farmers and agricultural cooperatives across Europe, particularly in France, Germany, and the Netherlands, where there is a high demand for sustainable farming solutions. The company's products are engineered to meet the needs of modern agriculture, ensuring safety for both users and the environment.The revenue structure of AmVac AG is anchored in direct sales to farmers and agricultural distributors, emphasizing a B2B model that facilitates efficient market penetration. Transactions typically involve bulk purchases of their flagship products, allowing clients to effectively meet their agricultural needs. Pricing strategies are aligned with the competitive landscape of agricultural inputs, with tailored solutions designed for various scales of operations. AmVac AG also collaborates with agricultural retailers, thereby enhancing their distribution network and improving accessibility for end-users. This transactional framework supports a consistent revenue flow while advancing sustainable agriculture through strategic partnerships.AmVac AG plans to utilize the recent GRANT of EUR 5.50 mn to support the development of new biopesticide products aimed at enhanced efficacy and environmental safety. The company is also targeting expansion into new markets, specifically in eastern European countries, with plans to establish a presence by 2025. This strategic growth initiative is complemented by the increased investment from VPlus Management, which raised its stake in AmVac AG from 0.65% to 2% in October 2013.

## Funding rounds

- Series A, Feb 11, 2010, $2.8M — VPlus Management

## Investors

- VPlus Management (https://capitalatlas.ai/funds/vplus-management) — Series A